-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children
1
Use of Multiple Concurrent Antipsychotics in Children
Section 1. Basic Measure Information
1.A. Measure Name
Use of Multiple Concurrent Antipsychotics in Children
1.B. Measure Number
0126
1.C. Measure Description
Please provide a non-technical descript…
-
qualityindicators.ahrq.gov/Downloads/Resources/Publications/2013/Empirical_Methods_r.pdf
January 01, 2013 - Esophageal Resection Volume*
IQI #2 – Pancreatic Resection Volume*
IQI #4 – Abdominal Aortic Aneurysm (AAA … Esophageal Resection Volume
IQI #2 - Pancreatic Resection Volume
IQI #4 - Abdominal Aortic Aneurysm (AAA … Resection Mortality Rate AM/PM X
IQI #9 - Pancreatic Resection Mortality Rate AM/PM X
IQI #11 - AAA
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2018qdr-appa4.pdf
January 01, 2018 - 26.1 3.64 MEPS 2016
Deaths per 1,000 adult hospital admissions with abdominal aortic aneurysm (AAA … 19.5 0.99 MEPS 2016
Deaths per 1,000 adult hospital admissions with abdominal aortic aneurysm (AAA … 30.1 3.44 MEPS 2016
Deaths per 1,000 adult hospital admissions with abdominal aortic aneurysm (AAA
-
hcup-us.ahrq.gov/db/nation/kid/KIDIntroduction2022.pdf
December 01, 2024 - c Where aaa denotes the body system and nnn denotes the CCSR number within the body
system. … d Where aaa denotes the clinical domain and nnn denotes the CCSR number within the clinical
domain.
-
hcup-us.ahrq.gov/reports/methods/2008_06.pdf
January 01, 2008 - Inpatient Quality Indicators
IQI 11 Deaths per 1,000 admissions with abdominal aortic aneurysm (AAA
-
hcup-us.ahrq.gov/reports/methods/2005_05.pdf
January 01, 2005 - transfers to another hospital)
IQI 11 Deaths per 1000 admissions with abdominal aortic aneurysm (AAA
-
hcup-us.ahrq.gov/reports/methods/2006_7.pdf
January 01, 2006 - transfers to another hospital)
IQI 11 Deaths per 1000 admissions with abdominal aortic aneurysm (AAA
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children
1
Use of Multiple Concurrent Antipsychotics in Children
Section 1. Basic Measure Information
1.A. Measure Name
Use of Multiple Concurrent Antipsychotics in Children
1.B. Measure Number
0126
1.C. Measure Description
Please provide a non-technical descript…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children
1
Use of Multiple Concurrent Antipsychotics in Children
Section 1. Basic Measure Information
1.A. Measure Name
Use of Multiple Concurrent Antipsychotics in Children
1.B. Measure Number
0126
1.C. Measure Description
Please provide a non-technical descript…
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children
1
Use of Multiple Concurrent Antipsychotics in Children
Section 1. Basic Measure Information
1.A. Measure Name
Use of Multiple Concurrent Antipsychotics in Children
1.B. Measure Number
0126
1.C. Measure Description
Please provide a non-technical descript…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children
1
Use of Multiple Concurrent Antipsychotics in Children
Section 1. Basic Measure Information
1.A. Measure Name
Use of Multiple Concurrent Antipsychotics in Children
1.B. Measure Number
0126
1.C. Measure Description
Please provide a non-technical descript…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children
1
Use of Multiple Concurrent Antipsychotics in Children
Section 1. Basic Measure Information
1.A. Measure Name
Use of Multiple Concurrent Antipsychotics in Children
1.B. Measure Number
0126
1.C. Measure Description
Please provide a non-technical descript…
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children
1
Use of Multiple Concurrent Antipsychotics in Children
Section 1. Basic Measure Information
1.A. Measure Name
Use of Multiple Concurrent Antipsychotics in Children
1.B. Measure Number
0126
1.C. Measure Description
Please provide a non-technical descript…
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents
1
Use of Higher-than-Recommended Doses of
Antipsychotics in Children and Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents
1.B.…